A citation-based method for searching scientific literature

Stephanie B Wheeler, Jennifer Spencer, Laura C Pinheiro, Caitlin C Murphy, Jo Anne Earp, Lisa Carey, Andrew Olshan, Chiu Kit Tse, Mary E Bell, Morris Weinberger, Katherine E Reeder-Hayes. J Natl Cancer Inst 2019
Times Cited: 38

List of co-cited articles
276 articles co-cited >1

Times Cited
  Times     Co-cited

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I Neugut. J Clin Oncol 2010

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
Caitlin C Murphy, L Kay Bartholomew, Melissa Y Carpentier, Shirley M Bluethmann, Sally W Vernon. Breast Cancer Res Treat 2012

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011

Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication.
Yihang Liu, Jennifer L Malin, Allison L Diamant, Amardeep Thind, Rose C Maly. Breast Cancer Res Treat 2013

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.
B Makubate, P T Donnan, J A Dewar, A M Thompson, C McCowan. Br J Cancer 2013

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
Gretchen Kimmick, Sara N Edmond, Hayden B Bosworth, Jeffrey Peppercorn, Paul K Marcom, Kimberly Blackwell, Francis J Keefe, Rebecca A Shelby. Breast 2015

Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL).
Dawn L Hershman, Lawrence H Kushi, Grace Clarke Hillyer, Ellie Coromilas, Donna Buono, Lois Lamerato, Dana H Bovbjerg, Jeanne S Mandelblatt, Wei-Yann Tsai, Xiaobo Zhong,[...]. Breast Cancer Res Treat 2016

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015

Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer.
N Lynn Henry, Faouzi Azzouz, Zereunesay Desta, Lang Li, Anne T Nguyen, Suzanne Lemler, Jill Hayden, Karineh Tarpinian, Elizabeth Yakim, David A Flockhart,[...]. J Clin Oncol 2012

Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?
Ekim Ekinci, Salima Nathoo, Thushara Korattyil, Aisha Vadhariya, Hanna A Zaghloul, Polly A Niravath, Susan M Abughosh, Meghana V Trivedi. J Cancer Surviv 2018

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Leah K Lambert, Lynda G Balneaves, A Fuchsia Howard, Carolyn C Gotay. Breast Cancer Res Treat 2018

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, Anna Moseley, Kathryn B Arnold, Shaker R Dakhil, Benjamin T Esparaz, Ming C Kuan, Mark L Graham, Douglas M Lackowski,[...]. J Clin Oncol 2020

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
Harold J Burstein, Christina Lacchetti, Holly Anderson, Thomas A Buchholz, Nancy E Davidson, Karen A Gelmon, Sharon H Giordano, Clifford A Hudis, Alexander J Solky, Vered Stearns,[...]. J Clin Oncol 2019

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.
C McCowan, J Shearer, P T Donnan, J A Dewar, M Crilly, A M Thompson, T P Fahey. Br J Cancer 2008

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
Paul E Goss, James N Ingle, Kathleen I Pritchard, Nicholas J Robert, Hyman Muss, Julie Gralow, Karen Gelmon, Tim Whelan, Kathrin Strasser-Weippl, Sheldon Rubin,[...]. N Engl J Med 2016

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006

Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
Moriah J Brier, Dianne L Chambless, Robert Gross, Jinbo Chen, Jun J Mao. Cancer 2017

Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.
Katherine L Kahn, Eric C Schneider, Jennifer L Malin, John L Adams, Arnold M Epstein. Med Care 2007

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016

Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
Dawn L Hershman, Jennifer Tsui, Jason D Wright, Ellie J Coromilas, Wei Yann Tsai, Alfred I Neugut. J Clin Oncol 2015

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Alfred I Neugut, Milayna Subar, Elizabeth Ty Wilde, Scott Stratton, Corey H Brouse, Grace Clarke Hillyer, Victor R Grann, Dawn L Hershman. J Clin Oncol 2011

Endocrine therapy initiation among Medicaid-insured breast cancer survivors with hormone receptor-positive tumors.
Stephanie Brooke Wheeler, Racquel Elizabeth Kohler, Katherine Elizabeth Reeder-Hayes, Ravi K Goyal, Kristen Hassmiller Lich, Alexis Moore, Timothy W Smith, Cathy L Melvin, Hyman Bernard Muss. J Cancer Surviv 2014

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010

Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.
Erin J Aiello Bowles, Denise M Boudreau, Jessica Chubak, Onchee Yu, Monica Fujii, Janet Chestnut, Diana S M Buist. J Oncol Pract 2012

Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time.
C Cluze, D Rey, L Huiart, M K BenDiane, A D Bouhnik, C Berenger, M P Carrieri, R Giorgi. Ann Oncol 2012

Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
Jennifer C Spencer, Bryce B Reeve, Melissa A Troester, Stephanie B Wheeler. Psychooncology 2020

Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer.
Catherine M Bender, Amanda L Gentry, Adam M Brufsky, Frances E Casillo, Susan M Cohen, Meredith M Dailey, Heidi S Donovan, Jacqueline Dunbar-Jacob, Rachel C Jankowitz, Margaret Q Rosenzweig,[...]. Oncol Nurs Forum 2014

Simulating Time-Dependent Patterns of Nonadherence by Patients With Breast Cancer to Adjuvant Oral Endocrine Therapy.
Eileen H Shinn, Gordon Broderick, Bryan Fellman, Ainslee Johnson, Elizabeth Wieland, Stacy Moulder, William Fraser Symmans. JCO Clin Cancer Inform 2019

COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy.
P Hadji, C Jackisch, W Bolten, M Blettner, H J Hindenburg, P Klein, K König, R Kreienberg, W Rief, D Wallwiener,[...]. Ann Oncol 2014

Racial differences in physical activity among breast cancer survivors: implications for breast cancer care.
Brionna Y Hair, Sandi Hayes, Chiu-Kit Tse, Mary Beth Bell, Andrew F Olshan. Cancer 2014

A qualitative exploration of race-based differences in social support needs of diverse women with breast cancer on adjuvant therapy.
Andrew J Paladino, Janeane N Anderson, J Carolyn Graff, Rebecca A Krukowski, Ryan Blue, Tameka N Jones, Joanne Buzaglo, Mehmet Kocak, Gregory A Vidal, Ilana Graetz. Psychooncology 2019

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.
Annette Wigertz, Johan Ahlgren, Marit Holmqvist, Tommy Fornander, Jan Adolfsson, Henrik Lindman, Leif Bergkvist, Mats Lambe. Breast Cancer Res Treat 2012

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Kunal C Kadakia, Claire F Snyder, Kelley M Kidwell, Nicholas J Seewald, David A Flockhart, Todd C Skaar, Zereunesay Desta, James M Rae, Julie L Otte, Janet S Carpenter,[...]. Oncologist 2016

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, Rodrigo Arriagada, Vinod Raina, Mirta Abraham, Victor Hugo Medeiros Alencar, Atef Badran, Xavier Bonfill,[...]. Lancet 2013

Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
Emma E Bright, Keith J Petrie, Ann H Partridge, Annette L Stanton. Breast Cancer Res Treat 2016

Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer.
J Brett, D Fenlon, M Boulton, N J Hulbert-Williams, F M Walter, P Donnelly, B Lavery, A Morgan, C Morris, E Watson. Eur J Cancer Care (Engl) 2018

Adherence to adjuvant hormonal therapy and its relationship to breast cancer recurrence and survival among low-income women.
Kathryn E Weaver, Fabian Camacho, Wenke Hwang, Roger Anderson, Gretchen Kimmick. Am J Clin Oncol 2013

Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017

Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta-analysis.
David J Finitsis, Brittany A Vose, Justin G Mahalak, Andrew L Salner. Psychooncology 2019

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.
Fabian T Camacho, Xi Tan, Héctor E Alcalá, Surbhi Shah, Roger T Anderson, Rajesh Balkrishnan. Medicine (Baltimore) 2017

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.